Armistice Capital, LLC Ovid Therapeutics Inc. Transaction History

Armistice Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $2.83 Million - $3.81 Million	-1,780,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $318,600 - $640,800	180,000 Added 11.25%	1,780,000 $3.15 Million
Q4 2018 Feb 14, 2019	BUY	$2.42 - $6.6 $3.87 Million - $10.6 Million	1,600,000 New	1,600,000 $3.87 Million

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $51.4M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.